Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Key Information
Due Date: November 5, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Not Specified
Match Required: No
Contact Info:
Overview
The Alzheimer's Drug Development Program is a funding opportunity that is set aside for medical research, specifically for pre-clinical and initial stage clinical trials (Phase I). The aim of this grant is to financially support the development of new drugs, both small-molecule and biologic. The fund is specifically interested in backing drug projects that focus on preventing Alzheimer's disease, slowing down its progression, or treating the cognitive and behavioral symptoms associated with the disease. Importantly, conducting a clinical trial is not a requirement to apply for this funding opportunity.
Show More
Key Dates
Open Date: Not Specified
Application Due Date: November 5, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- Unrestricted